Tekla Life Sciences Investors (HQL) — Cash Flow Quality Index
Tekla Life Sciences Investors (HQL) has a Cash Flow Quality Index of -0.01x as of September 2025. Operating cash flow of $-1.28 Million is below net income of $132.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore HQL cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tekla Life Sciences Investors Cash Flow Quality Index (1996–2025)
Historical Cash Flow Quality Index for Tekla Life Sciences Investors across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tekla Life Sciences Investors (HQL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Tekla Life Sciences Investors (1996–2025)
Year-by-year earnings quality comparison for Tekla Life Sciences Investors. For live market cap and the full company financial profile, see Tekla Life Sciences Investors (HQL) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.03x | $-2.32 Million | $85.59 Million | ▼ -236288.4% |
| 2021 | 0.00x | $-0.74 | $64.53K | ▲ +100.0% |
| 2014 | -0.59x | $-52.57K | $89.27K | ▼ -626.2% |
| 2013 | 0.11x | $9.47K | $84.64K | ▼ -58.8% |
| 2012 | 0.27x | $21.11 Million | $77.63 Million | ▼ -91.4% |
| 2011 | 3.16x | $118.30 Million | $37.47 Million | ▲ +1593.3% |
| 2010 | 0.19x | $1.90 Million | $10.19 Million | ▼ -4.8% |
| 2008 | 0.20x | $11.80 Million | $60.25 Million | ▲ +367.4% |
| 2007 | -0.07x | $-3.70 Million | $50.51 Million | ▼ -2.5% |
| 2005 | -0.07x | $-3.20 Million | $44.76 Million | ▲ +84.0% |
| 2004 | -0.45x | $-3.20 Million | $7.16 Million | ▼ -619.2% |
| 2003 | -0.06x | $-2.40 Million | $38.62 Million | ▲ +37.1% |
| 1997 | -0.10x | $-1.50 Million | $15.19 Million | ▼ -43.6% |
| 1996 | -0.07x | $-1.50 Million | $21.81 Million | — |